Veracyte (VCYT) CCO John Leite receives PSU shares, withholds stock for taxes

Rhea-AI Filing Summary

Veracyte, Inc. Chief Commercial Officer-CLIA John Leite reported equity-related transactions in company common stock. He acquired 47,149 shares on February 26, 2026 from vesting of performance-based restricted stock units after the board certified achievement of performance goals. On the same date, 8,905 shares were disposed at $38.75 per share to cover tax withholding obligations tied to this vesting, which the disclosure states does not represent a sale. Following these transactions, he directly owned 120,357 shares of Veracyte common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leite John

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer-CLIA

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A(1)		47,149	A	$0	129,262	D
Common Stock	02/26/2026		F(2)		8,905	D	$38.75	120,357	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 17,221 PSUs vested on February 26, 2026, and the remaining 29,928 vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date.

2. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Veracyte (VCYT) report for John Leite?

Veracyte reported that Chief Commercial Officer-CLIA John Leite received 47,149 common shares from vesting performance-based restricted stock units and had 8,905 shares withheld for taxes, all dated February 26, 2026, leaving him with 120,357 directly owned shares.

Was there an open-market sale in Veracyte (VCYT) stock by John Leite?

No, the filing states the 8,905 Veracyte shares were withheld to satisfy John Leite’s tax obligations from PSU vesting and “does not represent a sale,” indicating no open-market selling activity in this reported transaction.

How many Veracyte (VCYT) shares did John Leite acquire from PSU vesting?

John Leite acquired 47,149 Veracyte common shares upon vesting of performance-based restricted stock units on February 26, 2026, following board certification of performance. Of these units, 17,221 vested immediately and 29,928 are scheduled to vest on December 2, 2026, subject to continued service.

What is John Leite’s Veracyte (VCYT) share ownership after these transactions?

After the reported equity award and tax-withholding disposition, John Leite directly owned 120,357 shares of Veracyte common stock, according to the Form 4 disclosure summarizing his non-derivative holdings following the February 26, 2026 transactions.

Why were 8,905 Veracyte (VCYT) shares disposed of in John Leite’s Form 4?

The 8,905 disposed Veracyte shares were withheld to cover John Leite’s tax withholding obligations arising from the vesting of performance-based restricted stock units. The disclosure clarifies this disposition is solely for taxes and not a sale of shares.

What conditions apply to the remaining Veracyte (VCYT) performance-based RSUs for John Leite?

Of the performance-based RSUs underlying the reported award, 17,221 vested on February 26, 2026, while 29,928 are scheduled to vest on December 2, 2026, provided John Leite maintains continuous service with Veracyte through that future vesting date.